Solid organ and stem cell transplantation are life-saving procedures for patients with end-stage organ failure or hematologic malignancies, yet the post-transplant journey remains fraught with clinical complexity. Managing long-term immunosuppressive therapy, preventing and treating opportunistic infections like cytomegalovirus (CMV), and preserving graft function over time continue to challenge healthcare professionals (HCPs) across transplant care settings.
Our Transplant Hub is designed to provide clinicians, including transplant surgeons, nephrologists, hematologists, and allied HCPs, with the latest evidence-based strategies to improve transplant outcomes. This hub features focused educational activities such as exploring individualized approaches to immunosuppression using costimulation blockade in kidney transplantation and addressing the persistent burden of CMV infection in both kidney and stem cell transplant recipients. Together, these programs offer practical insights into therapeutic innovation, patient-centered care, and long-term management strategies that can help clinicians overcome ongoing barriers in transplantation medicine.
In this CME Outfitters recorded Grand Rounds series entitled, Versatility of Therapeutic uses of Costimulation Blockade in Kidney Transplantation, expert faculty will discuss strategies for identifying optimal immunosuppressive regimens, developing individualized management plans for patients who fail initial immunosuppressive therapy, and counseling patients with renal transplant on long-term immunosuppressive therapy.
In this CME Outfitters recorded Grand Rounds series, expert faculty will emphasize the burden of CMV in kidney transplantation and HSCT, review the benefits and limitations of current antiviral agents, and discuss the role of novel antivirals (e.g., letermovir and maribavir) for managing CMV. Additionally, case studies will demonstrate how to integrate novel antivirals into clinical practice to improve quality of care and outcomes.